Quick Answer
DNA X, Inc. reported Research And Development Expense of $14.24 million for the year ending 2024.
- DNA X, Inc. showed an increase of +703.3% in Research And Development Expense from 2023 to 2024.
- This data is from DNA X, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2018 to 2024), DNA X, Inc.'s Research And Development Expense has declined by 38.8%.
- Historical annual values: Fiscal year 2024: $14.24 million | Fiscal year 2023: $1.77 million | Fiscal year 2022: $7.97 million | Fiscal year 2021: $17.70 million | Fiscal year 2020: $16.22 million | Fiscal year 2019: $26.06 million | Fiscal year 2018: $23.25 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: